AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PHGE
  4. [8-K] BiomX Inc. Reports Material Event

[8-K] BiomX Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

BiomX Inc. (NYSE American: PHGE) filed a Form 8-K to disclose administrative details for its 2025 Annual Meeting of Stockholders.

  • Meeting date: Thursday, October 16, 2025
  • Record date: Close of business August 22, 2025
  • Shareholder proposal deadline: 5:00 p.m. ET, August 15, 2025 (per Rule 14a-8)

The disclosure is required because the meeting date moves more than 30 days from last year鈥檚 meeting, resetting SEC and bylaw timelines. No financial results, transactions, or leadership changes were reported.

BiomX Inc. (NYSE American: PHGE) ha presentato un modulo 8-K per comunicare i dettagli amministrativi relativi all'Assemblea Annuale degli Azionisti del 2025.

  • Data dell'assemblea: gioved矛 16 ottobre 2025
  • Data di registrazione: fine attivit脿 del 22 agosto 2025
  • Scadenza per le proposte degli azionisti: ore 17:00 ET, 15 agosto 2025 (secondo la Regola 14a-8)

La comunicazione 猫 necessaria poich茅 la data dell'assemblea si sposta di oltre 30 giorni rispetto a quella dell'anno scorso, azzerando i termini della SEC e dello statuto. Non sono stati riportati risultati finanziari, transazioni o cambiamenti nella leadership.

BiomX Inc. (NYSE American: PHGE) present贸 un Formulario 8-K para revelar detalles administrativos de su Reuni贸n Anual de Accionistas de 2025.

  • Fecha de la reuni贸n: jueves 16 de octubre de 2025
  • Fecha de registro: cierre de operaciones del 22 de agosto de 2025
  • Fecha l铆mite para propuestas de accionistas: 5:00 p.m. ET, 15 de agosto de 2025 (seg煤n la Regla 14a-8)

La divulgaci贸n es necesaria porque la fecha de la reuni贸n se mueve m谩s de 30 d铆as respecto a la reuni贸n del a帽o pasado, reiniciando los plazos de la SEC y los estatutos. No se reportaron resultados financieros, transacciones ni cambios en el liderazgo.

BiomX Inc. (NYSE American: PHGE)電� 2025雲� 欤检＜齑濏殞 頄夓爼 靹鸽秬靷暛鞚� 瓿店皽頃橁赴 鞙勴暣 8-K 鞏戩嫕鞚� 鞝滌稖頄堨姷雼堧嫟.

  • 齑濏殞 雮犾: 2025雲� 10鞗� 16鞚� 氇╈殧鞚�
  • 旮办鞚�: 2025雲� 8鞗� 22鞚� 鞓侅梾 膦呺 鞁滌爯
  • 欤检＜ 鞝滌晥 毵堦皭鞚�: 2025雲� 8鞗� 15鞚� 鞓ろ泟 5鞁�(霃欕秬鞁滉皠), 攴滌箼 14a-8鞐� 霐半

鞚措矆 瓿奠嫓電� 齑濏殞 雮犾臧� 鞛戨厔 齑濏殞 雮犾氤措嫟 30鞚� 鞚挫儊 氤�瓴诫悩鞏� SEC 氚� 鞝曣磤 鞚检爼鞚� 齑堦赴頇旊悩旮� 霑岆鞐� 頃勳殧頃╇媹雼�. 鞛 瓴瓣臣, 瓯半灅 霕愲姅 毽崝鞁� 氤�瓴� 靷暛鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.

BiomX Inc. (NYSE American : PHGE) a d茅pos茅 un formulaire 8-K pour divulguer les d茅tails administratifs de son assembl茅e annuelle des actionnaires de 2025.

  • Date de l鈥檃ssembl茅e : jeudi 16 octobre 2025
  • Date d鈥檈nregistrement : cl么ture des activit茅s le 22 ao没t 2025
  • Date limite pour les propositions des actionnaires : 15 ao没t 2025 脿 17h00 ET (conform茅ment 脿 la r猫gle 14a-8)

Cette divulgation est n茅cessaire car la date de l鈥檃ssembl茅e est d茅plac茅e de plus de 30 jours par rapport 脿 celle de l鈥檃nn茅e derni猫re, r茅initialisant ainsi les d茅lais de la SEC et des statuts. Aucun r茅sultat financier, transaction ou changement de direction n鈥檃 茅t茅 signal茅.

BiomX Inc. (NYSE American: PHGE) hat ein Formular 8-K eingereicht, um administrative Details f眉r die Hauptversammlung 2025 der Aktion盲re offenzulegen.

  • Versammlungsdatum: Donnerstag, 16. Oktober 2025
  • Stichtag: Gesch盲ftsschluss am 22. August 2025
  • Frist f眉r Aktion盲rsantr盲ge: 15. August 2025, 17:00 Uhr ET (gem盲脽 Regel 14a-8)

Die Offenlegung ist erforderlich, weil sich das Versammlungsdatum um mehr als 30 Tage gegen眉ber dem Vorjahr verschiebt, wodurch die Fristen der SEC und der Satzung zur眉ckgesetzt werden. Es wurden keine Finanzergebnisse, Transaktionen oder F眉hrungswechsel gemeldet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine administrative 8-K; schedules 2025 annual meeting, sets proposal/record dates; no impact on valuation.

This filing simply updates governance timelines. Investors gain clarity on when to submit proposals and who will be eligible to vote, but there are no operating metrics, strategy shifts, or capital actions. Consequently the information is non-material for earnings models or stock valuation. Compliance with SEC rules appears standard.

BiomX Inc. (NYSE American: PHGE) ha presentato un modulo 8-K per comunicare i dettagli amministrativi relativi all'Assemblea Annuale degli Azionisti del 2025.

  • Data dell'assemblea: gioved矛 16 ottobre 2025
  • Data di registrazione: fine attivit脿 del 22 agosto 2025
  • Scadenza per le proposte degli azionisti: ore 17:00 ET, 15 agosto 2025 (secondo la Regola 14a-8)

La comunicazione 猫 necessaria poich茅 la data dell'assemblea si sposta di oltre 30 giorni rispetto a quella dell'anno scorso, azzerando i termini della SEC e dello statuto. Non sono stati riportati risultati finanziari, transazioni o cambiamenti nella leadership.

BiomX Inc. (NYSE American: PHGE) present贸 un Formulario 8-K para revelar detalles administrativos de su Reuni贸n Anual de Accionistas de 2025.

  • Fecha de la reuni贸n: jueves 16 de octubre de 2025
  • Fecha de registro: cierre de operaciones del 22 de agosto de 2025
  • Fecha l铆mite para propuestas de accionistas: 5:00 p.m. ET, 15 de agosto de 2025 (seg煤n la Regla 14a-8)

La divulgaci贸n es necesaria porque la fecha de la reuni贸n se mueve m谩s de 30 d铆as respecto a la reuni贸n del a帽o pasado, reiniciando los plazos de la SEC y los estatutos. No se reportaron resultados financieros, transacciones ni cambios en el liderazgo.

BiomX Inc. (NYSE American: PHGE)電� 2025雲� 欤检＜齑濏殞 頄夓爼 靹鸽秬靷暛鞚� 瓿店皽頃橁赴 鞙勴暣 8-K 鞏戩嫕鞚� 鞝滌稖頄堨姷雼堧嫟.

  • 齑濏殞 雮犾: 2025雲� 10鞗� 16鞚� 氇╈殧鞚�
  • 旮办鞚�: 2025雲� 8鞗� 22鞚� 鞓侅梾 膦呺 鞁滌爯
  • 欤检＜ 鞝滌晥 毵堦皭鞚�: 2025雲� 8鞗� 15鞚� 鞓ろ泟 5鞁�(霃欕秬鞁滉皠), 攴滌箼 14a-8鞐� 霐半

鞚措矆 瓿奠嫓電� 齑濏殞 雮犾臧� 鞛戨厔 齑濏殞 雮犾氤措嫟 30鞚� 鞚挫儊 氤�瓴诫悩鞏� SEC 氚� 鞝曣磤 鞚检爼鞚� 齑堦赴頇旊悩旮� 霑岆鞐� 頃勳殧頃╇媹雼�. 鞛 瓴瓣臣, 瓯半灅 霕愲姅 毽崝鞁� 氤�瓴� 靷暛鞚� 氤搓碃霅橃 鞎婌晿鞀惦媹雼�.

BiomX Inc. (NYSE American : PHGE) a d茅pos茅 un formulaire 8-K pour divulguer les d茅tails administratifs de son assembl茅e annuelle des actionnaires de 2025.

  • Date de l鈥檃ssembl茅e : jeudi 16 octobre 2025
  • Date d鈥檈nregistrement : cl么ture des activit茅s le 22 ao没t 2025
  • Date limite pour les propositions des actionnaires : 15 ao没t 2025 脿 17h00 ET (conform茅ment 脿 la r猫gle 14a-8)

Cette divulgation est n茅cessaire car la date de l鈥檃ssembl茅e est d茅plac茅e de plus de 30 jours par rapport 脿 celle de l鈥檃nn茅e derni猫re, r茅initialisant ainsi les d茅lais de la SEC et des statuts. Aucun r茅sultat financier, transaction ou changement de direction n鈥檃 茅t茅 signal茅.

BiomX Inc. (NYSE American: PHGE) hat ein Formular 8-K eingereicht, um administrative Details f眉r die Hauptversammlung 2025 der Aktion盲re offenzulegen.

  • Versammlungsdatum: Donnerstag, 16. Oktober 2025
  • Stichtag: Gesch盲ftsschluss am 22. August 2025
  • Frist f眉r Aktion盲rsantr盲ge: 15. August 2025, 17:00 Uhr ET (gem盲脽 Regel 14a-8)

Die Offenlegung ist erforderlich, weil sich das Versammlungsdatum um mehr als 30 Tage gegen眉ber dem Vorjahr verschiebt, wodurch die Fristen der SEC und der Satzung zur眉ckgesetzt werden. Es wurden keine Finanzergebnisse, Transaktionen oder F眉hrungswechsel gemeldet.

false 0001739174 0001739174 2025-07-30 2025-07-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

Form 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): July 30, 2025

 

BiomX Inc.
(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-38762   82-3364020
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (I.R.S. Employer
Identification No.)

 

22 Einstein St., Floor 4

Ness Ziona, Israel

   7414003
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: +972 723942377

 

n/a
(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value   PHGE   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.08 Shareholder Director Nominations.

 

BiomX Inc. (the “Company”) expects to hold its 2025 Annual Meeting of Stockholders (the “Annual Meeting”) on Thursday, October 16, 2025 and has fixed the closing of business on August 22, 2025 as the record date for the Annual Meeting. Because the date of the Annual Meeting has been changed by more than 30 days from the anniversary date of the 2024 Annual Meeting of Stockholders, the Company is providing the due date for submission of any qualified stockholder proposal.

 

In accordance with Rule 14a-5(f) and Rule 14a-8(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the deadline for receipt of stockholder proposals for inclusion in the Company’s proxy statement for the Annual Meeting pursuant to Rule 14a-8 will be no later than 5:00 p.m., Eastern Time, August 15, 2025. Stockholder proposals must comply with all of the applicable requirements set forth in the rules and regulations of the Securities and Exchange Commission, including Rule 14a-8 under the Exchange Act and the Company’s Bylaws.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

BIOMX INC.  
     
By: /s/ Jonathan Solomon  
Name:  Jonathan Solomon  
Title: Chief Executive Officer  

 

Date: July 30, 2025

 

2

Source:

FAQ

When will BiomX (PHGE) hold its 2025 Annual Meeting?

The meeting is scheduled for Thursday, October 16, 2025.

What is the record date for BiomX's 2025 Annual Meeting?

Shareholders of record at the close of business on August 22, 2025 will be eligible to vote.

What is the deadline to submit shareholder proposals under Rule 14a-8?

Proposals must be received by 5:00 p.m. ET on August 15, 2025.

Why did BiomX file this 8-K?

The meeting date moved more than 30 days from the prior year, requiring disclosure of new proposal and record deadlines.

Does the filing contain any financial or operational updates?

No. The 8-K is limited to annual meeting logistics and contains no financial data or strategic announcements.
Stock PHGE logo
Biomx Inc

NYSE:PHGE

PHGE Rankings

#9769 Ranked by Market Cap
N/A Ranked by Dividends
#2 Top Loser

PHGE Latest News

Aug 6, 2025
BiomX to Report Second Quarter 2025 Financial Results and Program Updates on August 13, 2025
Jul 14, 2025
BiomX Announces Successful Initiation of Phase 2b Trial with First Patient Dosed in BX004 Program in Patients with Cystic Fibrosis
Jul 8, 2025
BiomX Announces Publication in Nature Communications of Phage Cocktail BX004 Phase 1b/2a Part 1 Data Demonstrating Strong Activity in Cystic Fibrosis
May 19, 2025
BiomX CEO Jonathan Solomon to Present at Biomed Israel 2025 Conference
May 15, 2025
BiomX Reports First Quarter 2025 Financial Results and Provides Business and Program Updates

PHGE Latest SEC Filings

Aug 5, 2025
[SCHEDULE 13G] BiomX Inc. SEC Filing
Jul 8, 2025
[8-K] BiomX Inc. Reports Material Event
Jun 23, 2025
[SCHEDULE 13D/A] BiomX Inc. SEC Filing

PHGE Stock Data

11.39M
19.97M
19.08%
47.7%
7.71%
Biotechnology
Biological Products, (no Disgnostic Substances)
Israel
NESS ZIONA